{"id":434,"date":"2021-04-23T11:33:17","date_gmt":"2021-04-23T11:33:17","guid":{"rendered":"https:\/\/precedenceresea-work.colibriwp.com\/news\/?p=434"},"modified":"2021-04-23T11:33:17","modified_gmt":"2021-04-23T11:33:17","slug":"crispr-cas-genes-market","status":"publish","type":"post","link":"https:\/\/precedenceresea-work.colibriwp.com\/news\/crispr-cas-genes-market\/","title":{"rendered":"CRISPR &#038; Cas Genes Market to Surpass a Valuation of US$ 4.23 billion by 2027"},"content":{"rendered":"<p><strong>The global CRISPR &amp; Cas Genes Market is expected to hit USD 4.23 bn by 2027 and the market is to expand at 16.02% CAGR from 2020 to 2027.<\/strong><\/p>\n<p style=\"text-align: center;\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone  wp-image-449\" src=\"https:\/\/precedenceresea-work.colibriwp.com\/news\/wp-content\/uploads\/2021\/04\/CRISPR-Cas-Genes-Market-300x175.png\" alt=\"\" width=\"485\" height=\"283\" srcset=\"https:\/\/precedenceresea-work.colibriwp.com\/news\/wp-content\/uploads\/2021\/04\/CRISPR-Cas-Genes-Market-300x175.png 300w, https:\/\/precedenceresea-work.colibriwp.com\/news\/wp-content\/uploads\/2021\/04\/CRISPR-Cas-Genes-Market-1024x597.png 1024w, https:\/\/precedenceresea-work.colibriwp.com\/news\/wp-content\/uploads\/2021\/04\/CRISPR-Cas-Genes-Market-768x447.png 768w, https:\/\/precedenceresea-work.colibriwp.com\/news\/wp-content\/uploads\/2021\/04\/CRISPR-Cas-Genes-Market.png 1150w\" sizes=\"(max-width: 485px) 100vw, 485px\" \/><\/p>\n<p>A new study on the global CRISPR &amp; Cas Genes market has been published by Precedence Research. It presents a wealth of information on key market dynamics, including the drivers, market trends, and challenges, as well as the structure of the global CRISPR &amp; Cas Genes market. The study offers valuable information about the global CRISPR &amp; Cas Genes market to illustrate how the market would grow during the forecast period 2020-2027. The report provides the value and volume of the global CRISPR &amp; Cas Genes market for the period 2020\u20132027, considering 2019 as the base year and 2027 as the forecast year. The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study.<\/p>\n<p>Key indicators of market growth, which include value chain as well as supply chain analyses, and Compound Annual Growth Rate (CAGR), are elucidated in the study in a comprehensive manner. This data can help readers interpret quantitative growth aspects of the global CRISPR &amp; Cas Genes market during the forecast period.<\/p>\n<p><strong>Get the Sample Pages of Report@ <a href=\"https:\/\/www.precedenceresearch.com\/sample\/1108\">https:\/\/www.precedenceresearch.com\/sample\/1108<\/a> <\/strong><\/p>\n<p>An extensive analysis on business strategies of leading market players is also featured in study on the global CRISPR &amp; Cas Genes market. This can help readers understand principal factors to foresee growth in the global CRISPR &amp; Cas Genes market. In this study, readers can also find specific data on the qualitative and quantitative growth avenues for the global market, which is expected to guide market players in making apt decisions in the future.<\/p>\n<p>The report also delves into the competition landscape of the global CRISPR &amp; Cas Genes market. Key players operating in the global market have been identified, and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global market report.<\/p>\n<p><strong>Some of the prominent players in the CRISPR &amp; Cas Genes market include:<\/strong><\/p>\n<ul>\n<li>Caribou Biosciences, Inc.<\/li>\n<li>F. Hoffmann-La Roche Ltd.<\/li>\n<li>Cellectis<\/li>\n<li>AstraZeneca<\/li>\n<li>Editas Medicine, Inc.<\/li>\n<li>Addgene<\/li>\n<li>Egenesis<\/li>\n<li>Horizon Discovery Group Plc<\/li>\n<li>Intellia Therapeutics, Inc.<\/li>\n<li>Genscrip<\/li>\n<li>Danaher Corporation<\/li>\n<li>Lonza<\/li>\n<li>Merck KGaA<\/li>\n<li>Synthego<\/li>\n<li>Mammoth Biosciences<\/li>\n<li>Inscripta, Inc.<\/li>\n<li>Cibus<\/li>\n<li>New England BioLabs<\/li>\n<li>Takara Bio, Inc.<\/li>\n<\/ul>\n<p><strong>Key Questions Answered in CRISPR &amp; Cas Genes Market Study<\/strong><\/p>\n<p>&#8211; What will be the CAGR of the global CRISPR &amp; Cas Genes market between 2016 and 2027?<\/p>\n<p>&#8211; What is the future scope and changing trends in technologies in the global CRISPR &amp; Cas Genes market?<\/p>\n<p>&#8211; Which factors will impede the growth of the global CRISPR &amp; Cas Genes market during the forecast period?<\/p>\n<p>&#8211; Which are the leading companies in the global CRISPR &amp; Cas Genes market?<\/p>\n<p>&#8211; Which region is set to expand at the fastest CAGR during the forecast period?<\/p>\n<p>&#8211; Which segment will have the highest revenue globally in 2027 and which segment will expand at the fastest CAGR during the forecast period?<\/p>\n<p>&#8211; What are the key factors influencing the CRISPR &amp; Cas Genes market in each region?<\/p>\n<p>&#8211; Which are the leading companies in the global CRISPR &amp; Cas Genes market?<\/p>\n<p>&#8211; Which factors will impede the growth of the global CRISPR &amp; Cas Genes market during the forecast period?<\/p>\n<p>&#8211; What is the volume (Units) of different CRISPR &amp; Cas Genes across all regions during the forecast period?<\/p>\n<p><strong>Get Customization on this Research Report@ <a href=\"https:\/\/www.precedenceresearch.com\/customization\/1108\">https:\/\/www.precedenceresearch.com\/customization\/1108<\/a> <\/strong><\/p>\n<p><strong>Research Methodology<\/strong><\/p>\n<p>A unique research methodology has been utilized by precedence research to conduct a comprehensive research on the growth of the global CRISPR &amp; Cas Genes market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.<\/p>\n<p>Secondary sources referred to by analysts during the production of the global CRISPR &amp; Cas Genes market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.<\/p>\n<p>These primary and secondary sources provided exclusive information during interviews, which serves as a validation from CRISPR &amp; Cas Genes industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped in making precedence research estimates on the future prospects of the global market more reliable and accurate.<\/p>\n<p><strong>Segments Covered in the Report<\/strong><\/p>\n<p><strong>By Product &amp; Service<\/strong><\/p>\n<ul>\n<li>By Service\n<ul>\n<li>Microbial Gene Editing<\/li>\n<li>Cell Line Engineering<\/li>\n<li>gRNA Design<\/li>\n<li>DNA Synthesis<\/li>\n<\/ul>\n<\/li>\n<li>By Product\n<ul>\n<li>Design Tool<\/li>\n<li>Kits &amp; Enzymes<\/li>\n<li>Libraries<\/li>\n<li>Antibodies<\/li>\n<li>Others<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><strong>By Application<\/strong><\/p>\n<ul>\n<li>Agricultural<\/li>\n<li>Biomedical\n<ul>\n<li>Functional Genomics<\/li>\n<li>Genome Engineering<\/li>\n<li>Disease Model Studies<\/li>\n<li>Epigenetics<\/li>\n<li>Others<\/li>\n<\/ul>\n<\/li>\n<li><strong>End-use Outlook<\/strong>\n<ul>\n<li>Contract Research Organizations (CROs),<\/li>\n<li>Academics &amp; Government Research Institutes<\/li>\n<li>Biotechnology &amp; Pharmaceutical Companies<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><strong>By Regional Outlook<\/strong><\/p>\n<ul>\n<li>North America\n<ul>\n<li>U.S.<\/li>\n<li>Canada<\/li>\n<\/ul>\n<\/li>\n<li>Europe\n<ul>\n<li>U.K.<\/li>\n<li>Germany<\/li>\n<li>France<\/li>\n<\/ul>\n<\/li>\n<li>Asia Pacific\n<ul>\n<li>China<\/li>\n<li>India<\/li>\n<li>Japan<\/li>\n<li>South Korea<\/li>\n<\/ul>\n<\/li>\n<li>Middle East &amp; Africa<\/li>\n<li>Latin America<\/li>\n<\/ul>\n<p><strong>Get Full Access of this Research Report, Click here@ <a href=\"https:\/\/www.precedenceresearch.com\/checkout\/1108\">https:\/\/www.precedenceresearch.com\/checkout\/1108<\/a> <\/strong><\/p>\n<p><strong>Contact Us:<\/strong><\/p>\n<p><strong>Precedence Research<br \/>\n<\/strong><br \/>\nApt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada<\/p>\n<p><strong>Call:<\/strong>\u00a0+1 9197 992 333<\/p>\n<p><strong>Email:\u00a0<\/strong><a href=\"mailto:sales@precedenceresearch.com\"><strong>sales@precedenceresearch.com<\/strong><\/a><\/p>\n<p><strong>Website: <\/strong><a href=\"https:\/\/www.precedenceresearch.com\"><strong>https:\/\/www.precedenceresearch.com<\/strong><\/a><\/p>\n<p><strong>Blog:<\/strong><a href=\"https:\/\/precedenceresearchreport.wordpress.com\"><strong>https:\/\/precedenceresearchreport.wordpress.com<\/strong><\/a><\/p>\n<p><strong>Follow us on <\/strong><a href=\"https:\/\/www.linkedin.com\/company\/precedence-research\/\"><strong>LinkedIn<\/strong><\/a><strong> | <\/strong><a href=\"https:\/\/twitter.com\/Precedence_R\"><strong>Twitter<\/strong><\/a><strong> | <\/strong><a href=\"https:\/\/www.facebook.com\/precedenceresearch\"><strong>Facebook<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The global CRISPR &amp; Cas Genes Market is expected to hit USD 4.23 bn by 2027 and the market is<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[931,938,935,934,937,939,933,936,932],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v16.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>CRISPR &amp; Cas Genes Market size hit US$ 4.23 billion by 2027<\/title>\n<meta name=\"description\" content=\"The global CRISPR &amp; Cas Genes Market is expected to hit USD 4.23 bn by 2027 and the market is to expand at 16.02% CAGR from 2020 to 2027.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/precedenceresea-work.colibriwp.com\/news\/crispr-cas-genes-market\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CRISPR &amp; Cas Genes Market size hit US$ 4.23 billion by 2027\" \/>\n<meta property=\"og:description\" content=\"The global CRISPR &amp; Cas Genes Market is expected to hit USD 4.23 bn by 2027 and the market is to expand at 16.02% CAGR from 2020 to 2027.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/precedenceresea-work.colibriwp.com\/news\/crispr-cas-genes-market\/\" \/>\n<meta property=\"og:site_name\" content=\"Precedence Research\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-23T11:33:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/precedenceresea-work.colibriwp.com\/news\/wp-content\/uploads\/2021\/04\/CRISPR-Cas-Genes-Market-300x175.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/precedenceresea-work.colibriwp.com\/news\/#website\",\"url\":\"https:\/\/precedenceresea-work.colibriwp.com\/news\/\",\"name\":\"news\",\"description\":\"Latest Research Reports\",\"publisher\":{\"@id\":\"https:\/\/precedenceresea-work.colibriwp.com\/news\/#\/schema\/person\/fdc6745e3f86c2ff637da48b398fe6f3\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":\"https:\/\/precedenceresea-work.colibriwp.com\/news\/?s={search_term_string}\",\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/precedenceresea-work.colibriwp.com\/news\/crispr-cas-genes-market\/#primaryimage\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/precedenceresea-work.colibriwp.com\/news\/wp-content\/uploads\/2021\/04\/CRISPR-Cas-Genes-Market.png\",\"contentUrl\":\"https:\/\/precedenceresea-work.colibriwp.com\/news\/wp-content\/uploads\/2021\/04\/CRISPR-Cas-Genes-Market.png\",\"width\":1150,\"height\":670,\"caption\":\"CRISPR & Cas Genes\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/precedenceresea-work.colibriwp.com\/news\/crispr-cas-genes-market\/#webpage\",\"url\":\"https:\/\/precedenceresea-work.colibriwp.com\/news\/crispr-cas-genes-market\/\",\"name\":\"CRISPR & Cas Genes Market size hit US$ 4.23 billion by 2027\",\"isPartOf\":{\"@id\":\"https:\/\/precedenceresea-work.colibriwp.com\/news\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/precedenceresea-work.colibriwp.com\/news\/crispr-cas-genes-market\/#primaryimage\"},\"datePublished\":\"2021-04-23T11:33:17+00:00\",\"dateModified\":\"2021-04-23T11:33:17+00:00\",\"description\":\"The global CRISPR & Cas Genes Market is expected to hit USD 4.23 bn by 2027 and the market is to expand at 16.02% CAGR from 2020 to 2027.\",\"breadcrumb\":{\"@id\":\"https:\/\/precedenceresea-work.colibriwp.com\/news\/crispr-cas-genes-market\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/precedenceresea-work.colibriwp.com\/news\/crispr-cas-genes-market\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/precedenceresea-work.colibriwp.com\/news\/crispr-cas-genes-market\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/precedenceresea-work.colibriwp.com\/news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CRISPR &#038; Cas Genes Market to Surpass a Valuation of US$ 4.23 billion by 2027\"}]},{\"@type\":\"Article\",\"@id\":\"https:\/\/precedenceresea-work.colibriwp.com\/news\/crispr-cas-genes-market\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/precedenceresea-work.colibriwp.com\/news\/crispr-cas-genes-market\/#webpage\"},\"author\":{\"@id\":\"https:\/\/precedenceresea-work.colibriwp.com\/news\/#\/schema\/person\/fdc6745e3f86c2ff637da48b398fe6f3\"},\"headline\":\"CRISPR &#038; Cas Genes Market to Surpass a Valuation of US$ 4.23 billion by 2027\",\"datePublished\":\"2021-04-23T11:33:17+00:00\",\"dateModified\":\"2021-04-23T11:33:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/precedenceresea-work.colibriwp.com\/news\/crispr-cas-genes-market\/#webpage\"},\"wordCount\":962,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/precedenceresea-work.colibriwp.com\/news\/#\/schema\/person\/fdc6745e3f86c2ff637da48b398fe6f3\"},\"image\":{\"@id\":\"https:\/\/precedenceresea-work.colibriwp.com\/news\/crispr-cas-genes-market\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/precedenceresea-work.colibriwp.com\/news\/wp-content\/uploads\/2021\/04\/CRISPR-Cas-Genes-Market-300x175.png\",\"keywords\":[\"CRISPR &amp; Cas Genes Market Analysis\",\"CRISPR &amp; Cas Genes Market CAGR\",\"CRISPR &amp; Cas Genes Market Forecast\",\"CRISPR &amp; Cas Genes Market Growth\",\"CRISPR &amp; Cas Genes Market Overview\",\"CRISPR &amp; Cas Genes Market Segment\",\"CRISPR &amp; Cas Genes Market Share\",\"CRISPR &amp; Cas Genes Market Size\",\"CRISPR &amp; Cas Genes Market Trends\"],\"articleSection\":[\"Healthcare\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/precedenceresea-work.colibriwp.com\/news\/crispr-cas-genes-market\/#respond\"]}]},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\/\/precedenceresea-work.colibriwp.com\/news\/#\/schema\/person\/fdc6745e3f86c2ff637da48b398fe6f3\",\"name\":\"precedenceresearchreports\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/precedenceresea-work.colibriwp.com\/news\/#personlogo\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/99c28380bf6247d2759dfd2680d189de?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/99c28380bf6247d2759dfd2680d189de?s=96&d=mm&r=g\",\"caption\":\"precedenceresearchreports\"},\"logo\":{\"@id\":\"https:\/\/precedenceresea-work.colibriwp.com\/news\/#personlogo\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","_links":{"self":[{"href":"https:\/\/precedenceresea-work.colibriwp.com\/news\/wp-json\/wp\/v2\/posts\/434"}],"collection":[{"href":"https:\/\/precedenceresea-work.colibriwp.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/precedenceresea-work.colibriwp.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/precedenceresea-work.colibriwp.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/precedenceresea-work.colibriwp.com\/news\/wp-json\/wp\/v2\/comments?post=434"}],"version-history":[{"count":1,"href":"https:\/\/precedenceresea-work.colibriwp.com\/news\/wp-json\/wp\/v2\/posts\/434\/revisions"}],"predecessor-version":[{"id":450,"href":"https:\/\/precedenceresea-work.colibriwp.com\/news\/wp-json\/wp\/v2\/posts\/434\/revisions\/450"}],"wp:attachment":[{"href":"https:\/\/precedenceresea-work.colibriwp.com\/news\/wp-json\/wp\/v2\/media?parent=434"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/precedenceresea-work.colibriwp.com\/news\/wp-json\/wp\/v2\/categories?post=434"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/precedenceresea-work.colibriwp.com\/news\/wp-json\/wp\/v2\/tags?post=434"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}